These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2120132)

  • 21. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
    Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
    J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa.
    Zweerink HJ; Gammon MC; Hutchison CF; Jackson JJ; Pier GB; Puckett JM; Sewell TJ; Sigal NH
    Infect Immun; 1988 May; 56(5):1209-14. PubMed ID: 3128480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and characterization of cDNAs coding for the heavy and light chains of a monoclonal antibody specific for Pseudomonas aeruginosa outer membrane protein I.
    Marget M; Eckhardt A; Ehret W; von Specht BU; Duchêne M; Domdey H
    Gene; 1988 Dec; 74(2):335-45. PubMed ID: 3149944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
    Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice.
    O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S
    Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-protective against infection with heterologous immunotype strains of P. aeruginosa.
    Lee NG; Ahn BY; Jung SB; Kim YG; Lee Y; Kim HS; Park WJ
    FEMS Immunol Med Microbiol; 1999 Sep; 25(4):339-47. PubMed ID: 10497864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A human monoclonal antibody cocktail for experimental mouse infection with clinically isolated strains of Pseudomonas aeruginosa].
    Miura S; Ishibashi Y; Arai T
    Kansenshogaku Zasshi; 1993 Dec; 67(12):1167-71. PubMed ID: 8294765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies against bacterial outer membrane antigens.
    Hancock RE; Mutharia LM
    Adv Exp Med Biol; 1985; 185():215-22. PubMed ID: 2416201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation on the protection of mice from infection with Pseudomonas aeruginosa using monoclonal antibodies].
    Ye DN; Wang CX; Yan RH; Dai BM; Ni HY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):188-90. PubMed ID: 3939267
    [No Abstract]   [Full Text] [Related]  

  • 32. Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.
    Torensma R; Fluit AC; Verhoef J
    Clin Infect Dis; 1994 Jul; 19(1):11-4. PubMed ID: 7948511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV.
    Frank DW; Vallis A; Wiener-Kronish JP; Roy-Burman A; Spack EG; Mullaney BP; Megdoud M; Marks JD; Fritz R; Sawa T
    J Infect Dis; 2002 Jul; 186(1):64-73. PubMed ID: 12089663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
    Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
    Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
    von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
    Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa.
    DiGiandomenico A; Keller AE; Gao C; Rainey GJ; Warrener P; Camara MM; Bonnell J; Fleming R; Bezabeh B; Dimasi N; Sellman BR; Hilliard J; Guenther CM; Datta V; Zhao W; Gao C; Yu XQ; Suzich JA; Stover CK
    Sci Transl Med; 2014 Nov; 6(262):262ra155. PubMed ID: 25391481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
    Faezi S; Sattari M; Mahdavi M; Roudkenar MH
    Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.